Vesa-Pekka Heikkilä1. 1. Department of Oncology and Radiotherapy, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Abstract
OBJECTIVE: Spacer gel is used to reduce the rectal dose in prostate radiotherapy. It is injected to increase the distance between the prostate and rectum. During the course of external radiotherapy treatment, physiological changes in rectal volume exist. When using polyethylene glycol material, such as DuraSeal(®) (Covidien, Mansfield, MA), gel resorption also occurs. Together, these factors alter the original dose plan distribution. METHODS: External dose planning and calculations were simulated using images acquired from 10 patients who were treated with brachytherapy and gel. The CT series was taken relative to gel injection: pre 1 day, post 1 day, post 1 month and post 2 months. Adaptive planning was compared with a single plan. RESULTS: Adaptive planning shows better results compared with the single plan used in the total treatment course; however, the effect is minor. CONCLUSION: Gel usage is clearly favourable to rectal DVH. Using adaptive planning with gel improves rectal DVH but is not necessary according to this study. ADVANCES IN KNOWLEDGE: Spacer gel is used in prostate radiotherapy to increase distance between the prostate and the rectum, thus reducing the rectal doses. During the treatment course, gel resorption exists which affects the rectal doses. The usefulness of adaptive planning to compensate this resorption effect has not been studied before.
OBJECTIVE: Spacer gel is used to reduce the rectal dose in prostate radiotherapy. It is injected to increase the distance between the prostate and rectum. During the course of external radiotherapy treatment, physiological changes in rectal volume exist. When using polyethylene glycol material, such as DuraSeal(®) (Covidien, Mansfield, MA), gel resorption also occurs. Together, these factors alter the original dose plan distribution. METHODS: External dose planning and calculations were simulated using images acquired from 10 patients who were treated with brachytherapy and gel. The CT series was taken relative to gel injection: pre 1 day, post 1 day, post 1 month and post 2 months. Adaptive planning was compared with a single plan. RESULTS: Adaptive planning shows better results compared with the single plan used in the total treatment course; however, the effect is minor. CONCLUSION: Gel usage is clearly favourable to rectal DVH. Using adaptive planning with gel improves rectal DVH but is not necessary according to this study. ADVANCES IN KNOWLEDGE: Spacer gel is used in prostate radiotherapy to increase distance between the prostate and the rectum, thus reducing the rectal doses. During the treatment course, gel resorption exists which affects the rectal doses. The usefulness of adaptive planning to compensate this resorption effect has not been studied before.
Authors: Damien C Weber; Thomas Zilli; Jean Paul Vallee; Michel Rouzaud; Raymond Miralbell; Luca Cozzi Journal: Int J Radiat Oncol Biol Phys Date: 2012-11-01 Impact factor: 7.038
Authors: Michael Pinkawa; Marc D Piroth; Richard Holy; Nuria Escobar-Corral; Mariana Caffaro; Victoria Djukic; Jens Klotz; Michael J Eble Journal: Radiother Oncol Date: 2013-01-16 Impact factor: 6.280
Authors: Danny Y Song; Klaus K Herfarth; Matthias Uhl; Michael J Eble; Michael Pinkawa; Baukelien van Triest; Robin Kalisvaart; Damien C Weber; Raymond Miralbell; Theodore L Deweese; Eric C Ford Journal: Int J Radiat Oncol Biol Phys Date: 2013-02-13 Impact factor: 7.038
Authors: Emile N J Th van Lin; Lisette P van der Vight; J Alfred Witjes; Henkjan J Huisman; Jan Willem Leer; Andries G Visser Journal: Int J Radiat Oncol Biol Phys Date: 2005-01-01 Impact factor: 7.038
Authors: Jennifer L Peterson; Steven J Buskirk; Michael G Heckman; Nancy N Diehl; Johnny R Bernard; Katherine S Tzou; Henry E Casale; Louis P Bellefontaine; Christopher Serago; Siyong Kim; Laura A Vallow; Larry C Daugherty; Stephen J Ko Journal: Med Dosim Date: 2013-10-04 Impact factor: 1.482
Authors: Matthias Uhl; Baukelien van Triest; Michael J Eble; Damien C Weber; Klaus Herfarth; Theodore L De Weese Journal: Radiother Oncol Date: 2013-01-16 Impact factor: 6.280